Pseudomyxoma Peritonei

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium

Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis

Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei

A Study of SGN-STNV in Advanced Solid Tumors

Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

HIPEC for Peritoneal Carcinomatosis

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

Severe Neutropenia After HIPEC Using Mitomycin-C

Gastrointestinal Microbiome Study of Appendiceal Cancer

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Phase I Trial HIPEC With Nal-irinotecan

Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies